Centered around a presentation on cardiovascular disease prevention and management in prostate cancer by Laurence Klotz, MD, FRCSC, of the University of Toronto, expert physicians Benjamin Maughan, MD, PharmD; Sandy Srinivas, MBBS; and Terence Friedlander, MD, provide insight on evolving strategies in patient education, lifestyle modification, multidisciplinary care, and more.
Understanding Risk Factors of Cardiovascular Disease and Management Guidance for Men on Androgen Deprivation Therapy With Prostate Cancer
Risk factors associated with cardiovascular disease (CVD) in men with prostate cancer
Prevention, management, and risk mitigation of CVD in prostate cancer
Proposed mechanisms of androgen deprivation therapy (ADT)–related CVD
Review of studies evaluating the association between ADT and CVD
Androgen Deprivation Therapy (ADT): Reducing Morbidity and Improving Outcome
How would you rate the Impact of this video in everyday practice?
